Recombinant Human KLRF1 Protein，GST

KLRF1, also known as Killer Cell Lectin-like Receptor F1, is a member of the C-type lectin-like receptor family and plays a significant role in the immune response, particularly in natural killer (NK) cell function. The receptor is primarily expressed on the surface of NK cells and has been implicated in the regulation of immune surveillance, tumor recognition, and the modulation of autoimmune diseases. Research has shown that KLRF1 can interact with various ligands, affecting NK cell activation and cytokine production. Its ability to recognize altered self-cells, such as those that have downregulated major histocompatibility complex (MHC) molecules, is crucial for effective anti-tumor immunity. Understanding the structure and function of KLRF1 is vital for the development of immunotherapies and vaccine strategies. Studies involving the recombinant expression of KLRF1 have been essential in elucidating its interactions and mechanisms of action, providing insights into how it can be manipulated to enhance immune responses against cancers and improve therapeutic outcomes. Additionally, the exploration of KLRF1's role in different pathological conditions underscores its potential as a biomarker and therapeutic target, making it a focus of ongoing research in immunology and cancer therapy. By further investigating KLRF1, researchers aim to uncover novel strategies for enhancing NK cell-mediated cytotoxicity and improving patient responses to existing therapies.